Founded by Dr. Leen Kawas and Richard Kayne, Propel Bio Partners invests in biosciences businesses with disruptive technologies, particularly those ready for clinical trials or regulatory approval. The firm provides capital and guidance, leveraging the expertise of its leadership team and board members from top biosciences companies. With offices in Los Angeles, Propel Bio Partners supports life science companies in advancing groundbreaking technologies and therapies for human health.